Compare BTMD & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTMD | DIT |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.0M | 79.1M |
| IPO Year | 2021 | 1996 |
| Metric | BTMD | DIT |
|---|---|---|
| Price | $2.20 | $70.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.83 | N/A |
| AVG Volume (30 Days) | ★ 404.5K | 378.0 |
| Earning Date | 05-06-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | ★ 722.22 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | $192,219,000.00 | ★ $1,392,388,157.00 |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $6.58 | N/A |
| P/E Ratio | $33.17 | ★ N/A |
| Revenue Growth | N/A | ★ 5.30 |
| 52 Week Low | $1.27 | $68.00 |
| 52 Week High | $4.75 | $126.50 |
| Indicator | BTMD | DIT |
|---|---|---|
| Relative Strength Index (RSI) | 53.69 | 37.72 |
| Support Level | $1.97 | N/A |
| Resistance Level | $2.44 | $120.08 |
| Average True Range (ATR) | 0.19 | 1.31 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 64.37 | 13.05 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.